Upcoming medical and pharmacy drug changes
Upcoming medical and pharmacy drug changes
March 30, 2026
Reminder: Submit drug prior authorization electronically
Drug prior authorization can be submitted electronically
February 13, 2026
Upcoming medical and pharmacy drug changes
Upcoming medical and pharmacy drug changes
February 3, 2026
GLP-1 Weight-loss drug coverage changes coming for Medicaid members
Effective Jan. 1, 2026, coverage and criteria of GLP-1 weight-loss drugs Saxenda, Wegovy and Zepbound will become more restrictive for all Michigan Medicaid members.
December 15, 2025
Commercial drug coverage changes coming for Tysabri and Revlimid
Commercial drug coverage changes coming for Tysabri and Revlimid
December 15, 2025
Dalvance® to be removed from coverage in place of generic
Effective. Feb. 4, 2026, Dalvance® will be removed from medical drug coverage for commercial group and individual members and replaced with its generic, Dalbavancin.
December 1, 2025
OxyContin® to be removed from formulary Jan. 1, 2026
OxyContin® to be removed from formulary Jan. 1, 2026
November 21, 2025
Steqeyma and Starjemza added to coverage
Steqeyma and Starjemza added to coverage to ensure access of Stelara biosimilars
November 21, 2025
10/28/2025: Drug coverage changes coming Jan. 1, 2026
Drug coverage changes coming for select members
October 28, 2025
10/15/2025: IXCHIQ and Ocaliva withdrawn from market due to safety concerns
IXCHIQ and Ocaliva withdrawn from the market due to potential safety concerns
October 15, 2025
09/03/2025: We've improved our Medical Benefit Drug List
Updating the format of our MBDL
September 3, 2025
09/02/2025: Coverage changes coming for OneTouch® and Accu-Chek Guide testing supplies
Changes to coverage for some diabetic supplies
August 29, 2025